Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zynex Inc (ZYXI)

Zynex Inc (ZYXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,799
  • Shares Outstanding, K 30,389
  • Annual Sales, $ 192,350 K
  • Annual Income, $ 2,990 K
  • EBIT $ -68 M
  • EBITDA $ -63 M
  • 60-Month Beta 0.99
  • Price/Sales 0.03
  • Price/Cash Flow 0.51
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.08
  • Most Recent Earnings $-0.41 on 11/17/25
  • Next Earnings Date 01/01/70
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.150 on 06/17/14
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Options Overview Details

View History
  • Implied Volatility 767.51% (+221.27%)
  • Historical Volatility 403.23%
  • IV Percentile 99%
  • IV Rank 84.87%
  • IV High 895.52% on 12/10/25
  • IV Low 49.17% on 03/06/25
  • Expected Move (DTE 19) 0.3910 (312.80%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 13
  • Volume Avg (30-Day) 216
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 5,589
  • Open Int (30-Day) 20,966
  • Expected Range 0.0000 to 0.5160

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +4,995,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1247 +0.24%
on 12/23/25
2.1000 -94.05%
on 11/26/25
-0.4929 (-79.77%)
since 11/21/25
3-Month
0.1247 +0.24%
on 12/23/25
2.1000 -94.05%
on 11/26/25
-1.4050 (-91.83%)
since 09/23/25
52-Week
0.1247 +0.24%
on 12/23/25
8.4500 -98.52%
on 01/27/25
-8.0950 (-98.48%)
since 12/23/24

Most Recent Stories

More News
Zynex Financial Restructuring Puts Company on Path to Long-Term Success

ENGLEWOOD, Colo. , Dec. 16, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

ZYXI : 0.1250 (-34.90%)
Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee

ENGLEWOOD, Colo. , Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

ZYXI : 0.1250 (-34.90%)
Zynex Sets Third Quarter 2025 Earnings Call

ENGLEWOOD, Colo. , Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

ZYXI : 0.1250 (-34.90%)
Analysts Offer Insights on Healthcare Companies: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) and Zynex (ZYXI)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD – Research Report) and Zynex (ZYXI –...

ZYXI : 0.1250 (-34.90%)
Analysts Offer Insights on Healthcare Companies: Zynex (ZYXI) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zynex (ZYXI – Research Report) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD –...

ZYXI : 0.1250 (-34.90%)
Zynex Expands Board, Appoints New Director

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Zynex ( (ZYXI)...

ZYXI : 0.1250 (-34.90%)
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair

ENGLEWOOD, Colo. , Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

ZYXI : 0.1250 (-34.90%)
Zynex Seeks Partner for NiCO CO-Oximeter Commercialization

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Zynex ( (ZYXI)...

ZYXI : 0.1250 (-34.90%)
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles

ENGLEWOOD, Colo. , Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 0.1250 (-34.90%)
Zynex Reports Second Quarter 2025 Financial Results

ENGLEWOOD, Colo. , July 31, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 0.1250 (-34.90%)

Business Summary

Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and...

See More

Key Turning Points

3rd Resistance Point 0.2497
2nd Resistance Point 0.2247
1st Resistance Point 0.1748
Last Price 0.1250
1st Support Level 0.0999
2nd Support Level 0.0749
3rd Support Level 0.0250

See More

52-Week High 8.4500
Fibonacci 61.8% 5.2697
Fibonacci 50% 4.2873
Fibonacci 38.2% 3.3050
Last Price 0.1250
52-Week Low 0.1247

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar